Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with TP53 Mutation

Blood (2023) 142 (Supplement 1): 6483.

https://doi.org/10.1182/blood-2023-186086

Published: 2023

Journal Articles

Higher Grade Cytokine Release Syndrome Is a Predictive Factor for Gvhd in Haploidentical Stem Cell Transplantation with Peripheral Blood Cell

Benjamin Bouchacourt, Valerio Maisano, Ana Benzaquen, Angela Granata, Sabine Furst, Faezeh Legrand, Thomas Pagliardini, Sandrine Loron, Samia Harbi, Pierre-Jean Weiller, Marie-Joelle Mozziconacci, Claude Lemarie, Boris Calmels, Christian Chabannon, Didier Blaise, Raynier Devillier

Blood (2021) 138 (Supplement 1): 2881.

https://doi.org/10.1182/blood-2021-151187

Published: 2021

Journal Articles

IDH Mutations Identify a Subgroup of NPM1 Patients with a More Favorable Prognosis. a Retrospective Multicenter Study of the Filo Group

Sylvain Garciaz, Marie Anne Hospital, Colombe Saillard, MD, Yosr Hicheri, Evelyne D'Incan, Jerome Rey, Catherine Lacombe, Arnaud Pigneux, MD PhD, Marie-Christine Béné, PharmSciD, PhD, Christian Recher, MD PhD, Marie-Joelle Mozziconacci, Norbert Vey, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-141229

Published: 2020

Journal Articles

Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia

Blood (2017) 130 (16): 1832–1844.

https://doi.org/10.1182/blood-2017-05-783852

Published: 2017

Includes: Supplemental data

Journal Articles

Whole Exome Analysis of Relapsing Patients with Acute Promyelocytic Leukemia

Cecile Bally, Jacqueline Lehmann-Che, Bruno Cassinat, PharmD, PhD, Lionel Ades, MD PhD, Eric Letouze, Pierre Hirsch, Marie-Joelle Mozziconacci, Sophie Raynaud, MD, Eric Delabesse, PharmD, PhD, Madalina Uzunov, MD, Mathilde Hunault, MD PhD, Eric Lippert, PhD, Hélène Lapillonne, MD PhD, Christophe Ferrand, PhD, Carine Gervais, MD, Nathalie Gachard, PhD, Agnès Guerci, MD PhD, Pierre Fenaux, MD PhD, Hugues de The, MD PhD

Blood (2016) 128 (22): 2892.

https://doi.org/10.1182/blood.V128.22.2892.2892

Published: 2016

Journal Articles

Characterization of Leukemias with ETV6-ABL1 Fusion

Blood (2015) 126 (23): 84.

https://doi.org/10.1182/blood.V126.23.84.84

Published: 2015

Journal Articles

H3K27me3 Level of the HIST1 Cluster Defines an Epigenetic Marker of Acute Myeloid Leukemia with Prognostic Value

Guillaume Tiberi, Aleksandra Pekowska, PhD, Claire Oudin, MD, Adam Ivey, Thomas Prebet, MD PhD, Myriam Koubi, Frederique Lembo, Marie-Joelle Mozziconacci, MD PhD, Ghislain Bidaut, PhD, Aurelie Autret, B.Sc., Christian Chabannon, MD PhD, David Grimwade, Norbert Vey, MD PhD, Salvatore Spicuglia, PhD, Boris Calmels, PharmD, PhD, Estelle Duprez, PhD

Blood (2014) 124 (21): 2326.

https://doi.org/10.1182/blood.V124.21.2326.2326

Published: 2014

Journal Articles

Value of Cytogenetic Abnormalities in Adult Patients with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) Treated in the Pediatric-Inspired Trials from the Group for Research on Adult ALL (GRAALL)

Blood (2014) 124 (21): 492.

https://doi.org/10.1182/blood.V124.21.492.492

Published: 2014

Journal Articles

The Comparative Value of Hematopoietic Stem Cell Transplantation and Chemotherapy in Cytogenetically Normal AML Subclassified By NPM1 Mutation Status and FLT3 -ITD Allelic Ratio

Blood (2014) 124 (21): 323.

https://doi.org/10.1182/blood.V124.21.323.323

Published: 2014

Journal Articles

Impact Of Anthracycline Dose Intensification On Minimal Residual Disease and Outcome Of Core Binding Factors Acute Myeloid Leukemias

Thomas Prebet, MD, PhD, Sarah Bertoli, Eric Delabesse, MD, PhD, Marie-Joelle Mozziconacci, MD, Anne Etienne, MD, Christian Recher, MD PhD, Françoise Huguet, Norbert Vey, MD

Blood (2013) 122 (21): 2681.

https://doi.org/10.1182/blood.V122.21.2681.2681

Published: 2013

Journal Articles

Prognostic Value of TP53 Gene Mutations in Higher Risk MDS Treated with Azacitidine

Cecile Bally, Lionel Ades, MD, PhD, Aline Renneville, MD, Claude Preudhomme, Marie-Joelle Mozziconacci, MD, PhD, Hugues de The, MD, PhD, Jacqueline Lehmann-Che, Pierre Fenaux, MD, PhD

Blood (2012) 120 (21): 1706.

https://doi.org/10.1182/blood.V120.21.1706.1706

Published: 2012

Journal Articles

Incidence and Prognostic Value of TP53 Mutations in Lower Risk MDS with Del 5q.

Cecile Bally, Lionel Ades, MD, PhD, Aline Renneville, MD, Sophie Raynaud, Virginie Eclache, MD, Thomas Cluzeau, MD, PhD, Mathilde Hunault-Berger, MD, PhD, Aspasia Stamatoullas, MD, Christian Bastard, MD, Michaela Fontenay, MD, PhD, Marie-Joelle Mozziconacci, MD, PhD, Claude Preudhomme, Hugues de The, MD, PhD, Pierre Fenaux, MD, PhD, Jacqueline Lehmann-Che, PharmD, PhD

Blood (2012) 120 (21): 2809.

https://doi.org/10.1182/blood.V120.21.2809.2809

Published: 2012

Journal Articles

Cytogenetic Abnormalities In a Cohort of 171 Patients with Waldenström Macroglobulinemia Before Treatment: Clinical and Biological Correlations

Blood (2010) 116 (21): 801.

https://doi.org/10.1182/blood.V116.21.801.801

Published: 2010

Journal Articles

Clinical Phenotype and Response to Imatinib of Chronic Myelogenous Leukemia Patients Harbouring Atypical BCR-ABL Transcripts. A Retrospective Analysis From the French Group of CML (Fi-LMC) and the French Group of Molecular Biologists for Hematological Malignancies (GBMHM).

Benedicte Deau, MD, Mathias Montveneur, MStud, Valérie Coiteux, MD, Aline Renneville, MD, Francoise Rigal-Huguet, MD, Eric Delabesse, MD, PhD, Michel Tulliez, MD, Dominique Bories, MD, PhD, Aude Charbonnier, MD, PhD, Marie-Joelle Mozziconacci, MD, PhD, Thibault Legay, MD, Eric Lippert, PhD, Francois-Xavier Mahon, MD, PhD, Delphine Rea, MD, PhD, Jean-Michel Cayuela, PhD, Shanti Amé, MD, Marie-Pierre Gaub, MD, Martine Gardembas, MD, Odile Blanchet, MD, Bruno Audhuy, MD, Agnès Buzyn, MD, PhD, Elisabeth Mac Intyre, MD, PhD, Anna-Lisa Andreoli, MD, Oumedaly Reman, Nathalie Contentin, MD, Christian Bastard, MD, Jean-Christophe Ianotto, MD, Valérie Ugo, MD, PhD, Jean-Jacques Kiladjian, MD, PhD, Said Brahimi, MD, Viviane Dubruille, Jean-Francois Brantus, MD, Mohamad Sobh, Pharm., M., Stephane Morisset, Stat., Claude Preudhomme, MD, PhD, Sandrine Hayette, PhD, Franck E Nicolini, MD, PhD

Blood (2010) 116 (21): 3378.

https://doi.org/10.1182/blood.V116.21.3378.3378

Published: 2010

Journal Articles

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study

Blood (2010) 115 (15): 3089–3097.

https://doi.org/10.1182/blood-2009-07-234229

Published: 2010

Includes: Supplemental data

Journal Articles

Chromosomal Abnormalities in Transformed Ph-Negative Myeloproliferative Neoplasm Are Independent of the JAK2 and the TET2 Statuses.

Blood (2009) 114 (22): 2900.

https://doi.org/10.1182/blood.V114.22.2900.2900

Published: 2009

Journal Articles

High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder

Claude Preudhomme, Aline Renneville, Violaine Bourdon, Nathalie Philippe, Catherine Roche-Lestienne, Nicolas Boissel, Nathalie Dhedin, Jean-Marie André, Pascale Cornillet-Lefebvre, André Baruchel, Marie-Joelle Mozziconacci, Hagay Sobol

Blood (2009) 113 (22): 5583–5587.

https://doi.org/10.1182/blood-2008-07-168260

Published: 2009

Includes: Supplemental data

Journal Articles

Impact of CRi on the Outcome of Elderly Patients with Untreated Acute Myeloid Leukemia (AML)

Anne Etienne, Aude Charbonnier, Thomas Prebet, Diane Coso, Evelyne D’Incan, Marie-Francoise Doglio, Daniele Sainty, Marie-Joelle Mozziconacci, Jerome Rey, Norbert Vey

Blood (2008) 112 (11): 2988.

https://doi.org/10.1182/blood.V112.11.2988.2988

Published: 2008

Journal Articles

Deletions of Chromosomes 6q and 13q, and Trisomy 4 Are the Most Common Cytogenetic Abnormalities in Waldenstrom Macroglobulinemia. Preliminary Results of a Multicentric Study.

Blood (2008) 112 (11): 1771.

https://doi.org/10.1182/blood.V112.11.1771.1771

Published: 2008

Journal Articles

JAK2 V617F Evaluation in Healthy Individuals with a Highly Sensitive Quantitative Assay

Christophe Martinaud, Nicolas Maroc, Fabienne Hermitte, PhD, Patrick Brisou, Marie-Joelle Mozziconacci

Blood (2008) 112 (11): 5241.

https://doi.org/10.1182/blood.V112.11.5241.5241

Published: 2008

NARROW

Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with TP53 Mutation

Higher Grade Cytokine Release Syndrome Is a Predictive Factor for Gvhd in Haploidentical Stem Cell Transplantation with Peripheral Blood Cell

IDH Mutations Identify a Subgroup of NPM1 Patients with a More Favorable Prognosis. a Retrospective Multicenter Study of the Filo Group

Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia

Whole Exome Analysis of Relapsing Patients with Acute Promyelocytic Leukemia

Characterization of Leukemias with ETV6-ABL1 Fusion

H3K27me3 Level of the HIST1 Cluster Defines an Epigenetic Marker of Acute Myeloid Leukemia with Prognostic Value

Value of Cytogenetic Abnormalities in Adult Patients with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) Treated in the Pediatric-Inspired Trials from the Group for Research on Adult ALL (GRAALL)

The Comparative Value of Hematopoietic Stem Cell Transplantation and Chemotherapy in Cytogenetically Normal AML Subclassified By NPM1 Mutation Status and FLT3 -ITD Allelic Ratio

Impact Of Anthracycline Dose Intensification On Minimal Residual Disease and Outcome Of Core Binding Factors Acute Myeloid Leukemias

Prognostic Value of TP53 Gene Mutations in Higher Risk MDS Treated with Azacitidine

Incidence and Prognostic Value of TP53 Mutations in Lower Risk MDS with Del 5q.

Cytogenetic Abnormalities In a Cohort of 171 Patients with Waldenström Macroglobulinemia Before Treatment: Clinical and Biological Correlations

Clinical Phenotype and Response to Imatinib of Chronic Myelogenous Leukemia Patients Harbouring Atypical BCR-ABL Transcripts. A Retrospective Analysis From the French Group of CML (Fi-LMC) and the French Group of Molecular Biologists for Hematological Malignancies (GBMHM).

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study

Chromosomal Abnormalities in Transformed Ph-Negative Myeloproliferative Neoplasm Are Independent of the JAK2 and the TET2 Statuses.

High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder

Impact of CRi on the Outcome of Elderly Patients with Untreated Acute Myeloid Leukemia (AML)

Deletions of Chromosomes 6q and 13q, and Trisomy 4 Are the Most Common Cytogenetic Abnormalities in Waldenstrom Macroglobulinemia. Preliminary Results of a Multicentric Study.

JAK2 V617F Evaluation in Healthy Individuals with a Highly Sensitive Quantitative Assay

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only